TLR10: Insights, controversies and potential utility as a therapeutic target.

doi:10.1111/sji.12988

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

TLR10: Insights, controversies and potential utility as a therapeutic target.

Scandinavian journal of immunology - 1 Apr 2021

Su Si-Biao, Tao Lin, Deng Ze-Ping, Chen Wen, Qin Shan-Yu, Jiang Hai-Xing

Abstract excerpt

The Toll-like receptor (TLR) family acts as a bridge connecting innate and acquired immunity. TLR10 remains one of the least understood members of this family. Some studies have examined TLR10 ligands, dimerization of TLR10 with other TLRs, and downstream signalling pathways and functions, but they have often arrived at conflicting conclusions. TLR10 can induce the production of proinflammatory cytokines by...

Topics

Animals
Autoimmune Diseases
Cytokines
Humans
Inflammation
Polymorphism, Single Nucleotide
Signal Transduction
Toll-Like Receptor 10

Source

Open in PubMed

Identifiers

PMID: 33047375
DOI: 10.1111/sji.12988

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics